Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 9Recruiting 8Active not recruiting 7Unknown 2Terminated 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 120sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89pembrolizumab 86Leucovorin 86toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Unknown × luprolide acetate gel depot × Clear all
NCT03380806 2020-06-04

PBS

Juravinski Cancer Center

Phase 2 Unknown
100 enrolled
Genitourinary

Prostatic Neoplasms

NCT00452556 2014-03-19

The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study

Nova Scotia Cancer Centre

Phase 2 Unknown
86 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡